Skip to main content
 

Innovators’ Network Member Medable Secures $91M in Funding

Innovators’ Network Member Medable Secures $91M in Funding

PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc. today announced $91 million in new funding to accelerate the life sciences industry’s shift to digital and decentralized clinical trials. The Series C funding round was led by Sapphire Ventures, with follow-on investment from existing investors GSR Ventures, PPD, Inc. (Nasdaq:PPD) and Streamlined Ventures. The funding brings Medable’s total capital raised to more than $136 million. For more, click here.

More News

  • Artificial Intelligence in the Clinic: Don’t Pay for the Tool, Pay for the Care

  • Brainomix Extends Series C Financing to $25.4M to Support U.S. Expansion

  • Dr. Eric Topol’s mentions CureMetrix: All Mammograms Should Incorporate A.I. | CureMetrix